Pfizer Free Cash Flow: 3.98B
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
PFE Free Cash Flow Rankings
| Overall | 99th percentile | 31 of 4280 |
| Sector | 99th percentile | 4 of 501 in Healthcare |
| Industry | 88th percentile | 3 of 25 in Drug Manufacturers - Major |
PFE Free Cash Flow Range, Past 5 Years
| Minimum | -476.00M | Mar 1999 |
| Maximum | 4.92B | Dec 2004 |
| Average |
About Free Cash Flow
Click "Learn More" below to see how YCharts calculates Free Cash Flow.
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
You may also be interested in these PFE related companies
PFE News
I understand why they have to do it, but it is a shame that $PFE is selling off those animal health and nutrition businesses. Good growth.
about 18 hours ago by bradloncar
about 18 hours ago by bradloncar
CORRECTING and REPLACING Branham Law Group Investigates Pfizer for Packaging Error Recall
Feb 10, 1:05PM Business Wire
Feb 10, 1:05PM Business Wire
News related to $PFE: 'FDA outlines path for lower-priced biotech drugs' http://stks.co/2L20
about 3 days ago by TradeBot
about 3 days ago by TradeBot
Branham Law Group Investigates Pfizer for Qualitest Packaging Error Recall
Feb 09, 2:19PM Business Wire
Feb 09, 2:19PM Business Wire
$pfe is at support. looking for a buy $dow http://stks.co/2J1W $$ #trading #dow #pfe #dji #djia
about 4 days ago by dariabarbu75
about 4 days ago by dariabarbu75
$PFE http://stks.co/2Ffs $PFE looks like it wants higher, my near term target = 23.00
about 7 days ago by daytrader111
about 7 days ago by daytrader111
$PFE Dow 30 - Zooming in to Payrolls - Feb 3rd 2012 - http://stks.co/2EAK
about 10 days ago by dow30
about 10 days ago by dow30
$PFE http://stks.co/2E86 5m, waiting for the chikou to break free - then I'm in. Need to formalize my plan on this one.
about 10 days ago by abdulalikon
about 10 days ago by abdulalikon
$PFE http://stks.co/2E83 Daily, hammering out the bottom. Waiting for Chikou to break through on the 5m then I'm in.
about 10 days ago by abdulalikon
about 10 days ago by abdulalikon
According to news article in Seattle Times today $PFE is recalling 1M birth control packs after mixup http://stks.co/2CHG
about 11 days ago by yaksierra
about 11 days ago by yaksierra
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| PFE | 21.05 | -0.09 | -0.43% | 161.81B |
| APA | 105.13 | -1.55 | -1.45% | 40.36B |
| ADI | 39.46 | -0.64 | -1.60% | 11.82B |
| BFLY | 2.13 | -0.00 | -0.12% | 52.36M |
| FREE | 0.64 | -0.06 | -8.59% | 4.15M |
| BIG | 44.00 | 0.16 | 0.36% | 2.88B |
| DHT | 1.08 | 0.00 | 0.00% | 67.41M |
| RKT | 68.04 | 0.53 | 0.79% | 4.80B |
| CTB | 15.93 | -0.62 | -3.75% | 991.80M |
| EDAP | 2.11 | -0.04 | -1.86% | 27.68M |
